Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

Blood Cancer J. 2015 Nov 27;5(11):e369. doi: 10.1038/bcj.2015.94.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / therapeutic use
  • Humans
  • Janus Kinase 2 / genetics
  • Mutation
  • Risk Factors
  • Thrombocythemia, Essential / complications
  • Thrombocythemia, Essential / diagnosis*
  • Thrombocythemia, Essential / epidemiology
  • Thrombocythemia, Essential / genetics
  • Thrombosis / classification
  • Thrombosis / epidemiology
  • Thrombosis / genetics
  • World Health Organization

Substances

  • JAK2 protein, human
  • Janus Kinase 2
  • Aspirin